USCI Japan Ltd.

January 18, 2006 03:00 ET

USCI Japan Launches USCI Ireland Medical Technology Venture in Ballinasloe

BALLINASLOE, Ireland--(CCNMatthews - Jan 18, 2006) -

USCI Japan Ltd., headquartered in Tokyo, today announced a EUR 10 million investment in a global research, development and manufacturing center of excellence to be located in Ballinasloe, Ireland. This strategic move by USCI will integrate its Japanese distribution system with R&D and manufacturing such that it can service new and existing customers with greater speed and accuracy in the interventional vascular market space. The Ballinasloe IDA Business and Technology Park was chosen for USCI's R&D and manufacturing center due to the highly educated and experienced workforce in the area. This operation is expected to create up to 125 jobs over four years. The positions will employ approximately 20% in R&D-related activities and the remainder in high-level manufacturing.

Ireland's Minister for Enterprise, Trade and Employment Micheal Martin TD, in his announcement said, "This is excellent news for Ballinasloe. The high-quality employment USCI will provide and its spending on salaries, goods and services will be a real boost to the area. USCI represents another important component in the expansive medical technologies infrastructure in Ireland and continues our aim to broaden the cluster of such companies in the Border Midlands West region."

Michael D. Van Zandt, President & CEO, USCI Japan Ltd., said, "Our primary goal in establishing this Center is to take advantage of the unique opportunity of directly linking the medical technology expertise of the West of Ireland to Japan, the most demanding and most sought-after market for the medical technology industry globally. Having researched several locations globally for this investment we decided on Ireland. Ballinasloe stood out as the ideal choice due to the availability of the highly skilled workforce and management, the extensive medical technology expertise in the area, and the business-friendly environment. Thanks to the Ballinasloe location, we have been able to attract an extremely talented Irish management team, led by Thomas Greaney, and we look forward to the ongoing recruitment of equally talented people in line with our business plan."

USCI is part of USCI Holdings, a specialized group of Japanese companies focused on the sales, marketing and distribution of interventional medical products. The Group consists of three separate entities: USCI Japan Ltd., MC Ltd. and MedCare Ltd.

Contact Information

  • USCI Japan Ltd.
    Michael Van Zandt, +81-3-3578-7780
    website: www.usci.co.jp